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however, administration of thermogenic molecules, such as 
central leptin or a peripheral 3-adrenoreceptor agonist, 
induced a significant increase in hypothalamic eCBs, sug-
gesting a directional link from BAT thermogenesis to hypo-
thalamic eCBs. This study contributes to the understanding of 
hypothalamic regulation of obesity.—Miralpeix, C., A. Fosch, 
J. Casas, M. Baena, L. Herrero, D. Serra, R. Rodríguez-
Rodríguez, and N. Casals. Hypothalamic endocannabinoids 
inversely correlate with the development of diet-induced 
obesity in male and female mice. J. Lipid Res. 2019. 60: 
1260–1269.
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The endocannabinoid (eCB) system is a highly conserved 
lipid-derived signaling system that plays a critical role in the 
control of energy homeostasis and body weight (1). The 
most well-known eCBs are 2-arachidonoylglycerol (2-AG) 
and N-arachidonoylethanolamine (anandamide; AEA). 
eCBs are synthetized on demand in the brain and periph-
eral tissues, where they can act in an autocrine or paracrine 
manner or be secreted to the bloodstream (2). In periph-
eral tissues, such as liver, fat, pancreas, and muscle, eCBs 
exert a wide range of metabolic effects, including the mod-
ulation of food digestion, energy expenditure, lipid storage, 
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and glucose homeostasis (3, 4). The overall action of eCBs 
in the periphery favors energy intake and storage, promot-
ing obesity development (1, 2). In humans, evidence dem-
onstrates that circulating 2-AG and/or AEA levels are 
increased in people with obesity, and these levels specifi-
cally correlate with visceral fat mass, either in female or 
male patients (5, 6).
The eCB signaling is particularly critical in the brain, 
where it modulates neurotransmitter release and provides 
neuroprotection (7, 8). The eCB system is widely ex-
pressed in brain areas associated with the regulation of 
energy homeostasis, like the hypothalamus, the brainstem, 
and the cortico-limbic system (7). In the hypothalamus, 
2-AG levels are increased in different genetic models of 
obesity: Zucker rats, db/db mice, or ob/ob mice (9). In line 
with these evidences, specific deletion of the main eCB re-
ceptor (CB1) in the hypothalamus resulted in increased 
energy expenditure and brown adipose tissue (BAT) ther-
mogenesis, leading to a reduction in body weight, while 
food intake remained unchanged (10). These studies, to-
gether with others on genetic animal models (11–13), 
suggest that the activation of the eCB system in the hypo-
thalamus leads to reduced energy expenditure and pro-
motes obesity (1).
Despite these findings in genetic models, the exact dy-
namic of eCB levels and their modulation in the hypothala-
mus during diet-induced obesity (DIO), the model that 
best resembles human obesity, has been poorly explored, 
and the scarce results in response to a high-fat diet (HFD) 
are contradictory. For instance, hypothalamic 2-AG levels 
were increased in rats after long-term exposure to an HFD 
(24 weeks) (14), whereas they were not changed in another 
study performed with mice fed an HFD for 19 weeks (15). 
In both studies, AEA levels remained unchanged. More-
over, the time-course fluctuations and regulation of the 
eCB profile in the hypothalamus during obesity develop-
ment remains incompletely described and understood.
In addition to this unsolved issue, recent evidence 
showed some differences in brain eCB levels between male 
and female mice after long-term administration of an HFD 
(16), in line with the sexually dimorphic brain response in 
obesity (17–19). However, eCB dynamics in the hypothala-
mus between male and female animals during DIO devel-
opment have not been explored.
In the present study, we have analyzed hypothalamic 
2-AG and AEA levels in male and female mice at different 
stages of DIO development. Our results demonstrate that 
2-AG and AEA levels transitorily increase in both genders, 
with maximum levels at 7 days of HFD administration, fol-
lowed by a gradual decline to levels similar to those ob-
served in control groups. These changes positively correlate 
with BAT thermogenesis and inversely correlate with body-
weight gain. Acute activation of BAT thermogenesis under 
different stimuli also increased eCB levels in the hypothala-
mus, indicating early rises in hypothalamic eCBs as a com-
pensatory response to the increased thermogenesis. This is 
the first study revealing the exact dynamic of hypothalamic 
2-AG and AEA during DIO development and its potential 
link to BAT activation in male and female mice.
METHODS
Animals, diets, and sample collection
Male and female C57BL/6J mice (8 weeks old) were used for 
the experiments. All animals were housed on a 12 h/12 h light/
dark cycle in a temperature- and humidity-controlled room and 
were allowed free access to water and standard laboratory chow. 
Animals were placed on an HFD (60% kcal from fat; catalog no. 
D12492, Research Diets, New Brunswick, NJ) or standard diet 
(SD) (10% kcal from fat; catalog no. D12450B, Research Diets) 
for 7, 14, 28, 60, or 90 days. Diets were administered in two dif-
ferent sets of animals: 1) mice fed an SD or HFD for 7, 14, or 28 
days; and 2) mice fed an SD or HFD for 60 or 90 days. At the 
end of the studies, animals were fasted for 1 h and euthanized 
by cervical dislocation, and tissues were collected for further 
molecular and biochemical analysis. For each animal, the hy-
pothalamus and interscapular BAT were quickly removed, 
weighed, and stored at 80°C. Plasma was obtained after blood 
centrifugation. Tissue processing and analysis from both sets of 
animals were simultaneously performed. All animal proce-
dures were performed in agreement with European guidelines 
(2010/63/EU) and approved by the University of Barcelona 
Local Ethical Committee (Procedure ref. 9659, Generalitat de 
Catalunya).
Extraction and analysis of eCBs
Hypothalamic and plasma eCBs from both sets of animals were 
simultaneously extracted and analyzed as previously described by 
Gong et al. (20). Hypothalamus (6–8 mg wet tissue) was dounce-
homogenized in 200 µl of ice-cooled deionized water containing a 
final concentration of 0.362 µM N-oleylethanolamine-d2 (OEA-d2) 
(Cayman Chemicals, Ann Arbor, MI) as internal standard for 
2-AG and AEA calibration, 100 µM PMSF, and 0.01% butylated 
hydroxytoluene (BHT) (Sigma-Aldrich, Madrid, Spain), followed 
by a brief sonication. After that, half of the homogenized sample 
was kept at 20°C for protein quantification, and the other half 
was mixed with 400 µl of ethyl acetate/n-hexane (9:1, v/v) and 
vortexed for 5 min. After centrifugation (14,000 g, 4°C, 5 min), 
the upper layer was collected and evaporated using a nitrogen 
evaporator.
Plasma (25 µl) was mixed with 0.362 µM OEA-d2, 100 µM 
PMSF, and 0.01% BHT per sample. Lipid extraction was made 
with 250 µl of ethyl acetate/n-hexane (9:1, v/v), following the 
same protocol as for hypothalamus extraction.
eCB levels were analyzed by LC/MS/MS, following the proto-
col described by Gong et al. (20). Briefly, 2-AG, AEA, and OEA-d2 
(Cayman Chemicals) were used for the calibration curve in 
an Acquity ultra-high-performance liquid chromatography 
(UPLC) (Waters, Singapore) system connected to a Xevo-TQS 
triple-quadropole Detector (Waters, Ireland) and controlled 
with Waters/Micromass MassLynx software. Chromatographic 
separation was performed on an Acquity UPLC BEH C18 col-
umn (1.7 µm particle size, 100 mm × 2.1 mm; Waters) with an 
isocratic mobile phase of formic acid 0.1% in water-acetonitrile 
(30:70, v/v). The flow rate was 0.3 ml/min. Detection was per-
formed with an electrospray interface operating in the positive 
ion mode. The capillary voltage was set to 3.1 kV, the source 
temperature was 150°C, and the desolvation temperature was 
500°C, acquiring the following selected reaction monitoring 
transitions: OAE-d2: 328.2–62.2 Da, cone voltage 50 V, and col-
lision energy 10 eV; AEA: 348.2–62.2 Da, cone voltage 50 V, and 
collision energy 10 eV; and 2-AG: 379.2–287.1 Da, cone voltage 
50 V, and collision energy 10 eV. eCB levels from each experi-
mental group were normalized to its corresponding control 
group (SD).
1262 Journal of Lipid Research Volume 60, 2019
Analysis of plasma leptin levels
Plasma levels of leptin were determined by a mouse ELISA Kit 
(Crystal Chem, Zaandam, The Netherlands), following the manu-
facturer’s instructions.
RNA preparation and quantitative RT-PCR
Total RNA was extracted from tissues using Trizol Reagent 
(Fisher Scientific, Madrid, Spain). Retrotranscription and quanti-
tative RT-PCR was performed as previously described (21). SYBR 
Green or Taqman Gene Expression assay primers were used (IDT 
DNA Technologies, Leuven, Belgium) (supplemental Table S1). 
Relative mRNA levels were measured using the CFX96 Real-time 
System, C1000 Thermal Cycler (Bio-Rad, Madrid, Spain).
BAT temperature measurements
Skin temperature surrounding BAT was visualized using a high-
resolution infrared camera (FLIR Systems) and analyzed with a 
specific software package (FLIR-Tools-Software, FLIR, Kent, UK), 
as described (22, 23). Thermal images were acquired the day of 
euthanization.
Icv administration of leptin and 2-AG + AEA combination
Two different experiments were performed: 1) icv leptin ad-
ministration followed by evaluation of BAT thermogenesis and 
hypothalamic eCB levels; and 2) icv administration of a mixture of 
eCBs that consists of combinations of 2-AG + AEA in different dos-
ages to evaluate BAT thermogenesis. For both experiments, can-
nulae were stereotaxically implanted into the lateral cerebral 
ventricle under ketamine/xylazine ip anesthesia, as previously de-
scribed (23). Lean mice fed a chow diet were individually caged 
and allowed to recover for 5 days before the experiment.
For leptin injection experiment. On the experimental day, lean 
male mice received an icv administration of 2 µl of either vehicle 
(aqueous buffer containing 0.1% BSA) or leptin (0.1 µg/µl) (Pe-
proTech, London, UK) 3 h after lights on (23). At 4 h after the 
injection, mice were euthanized by cervical dislocation, and hy-
pothalamus and BAT were collected for further analysis.
For eCBs injection experiment. On the experimental day, lean 
male mice received an icv administration of 2 µl of either vehicle 
(saline buffer containing 5% DMSO) or the eCB combination 
2-AG + AEA (Cayman Chemicals) in two different dosages: dose 1 
(0.5 µg of 2-AG + 0.005 µg of AEA) and dose 2 (2 µg of 2-AG + 0.02 
µg of AEA). The doses of 2-AG and AEA were selected based on 
previous publications using icv or intrahypothalamic administra-
tion of these eCBs separately (24, 25) and also considering the 
different range of concentration found in the hypothalamic re-
gion under standard conditions (×50–100 higher concentrations 
of 2-AG compared with AEA).
3-adrenergic agonist-induced thermogenesis activation
Hypothalamic eCB levels were determined after adrenergic 
stimulation of BAT thermogenesis with the selective 3-adrenergic 
agonist CL 316,243 (Tocris Bioscience, Bristol, UK) in lean mice, 
as previously described (26, 27). At 4 h after ip injection of either 
CL 316,243 (10 mg/kg) or vehicle (aqueous buffer) (26), mice 
were euthanized by cervical dislocation, and hypothalamus and 
BAT were collected for further analysis.
Statistical analysis
All results are expressed as mean ± SEM (n = 8–12). Analysis was 
conducted using GraphPad Prism 6 (GraphPad Software, La Jolla, 
CA). Statistical analysis was determined by one-way ANOVA when 
different diet groups within the same gender were compared and 
two-way ANOVA when groups between different genders were 
compared. In both cases, ANOVA was followed by a post hoc two-
tailed Bonferroni test. For the analysis of the relation between vari-
ables, parameters were mathematically log-transformed to improve 
symmetry, and correlation was analyzed by Pearson’s test and lin-
eal regression. P < 0.05 was considered significant.
RESULTS
Progression of DIO was delayed in female compared with 
male mice
Age-matched male and female mice were fed an SD or 
an HFD for 90 days. During this period, progression of 
body weight gain, plasmatic levels of leptin, food, and ca-
loric intake were evaluated (Fig. 1, supplemental Figs. S1, 
S2). Males fed an HFD for a period of administration equal 
to or longer than 28 days gained significantly more weight 
than controls (Fig. 1A, supplemental Fig. S1). In female 
mice, a significant increase in body weight gain was not ap-
preciated until 60 days of administration of an HFD com-
pared with an SD (Fig. 1A, supplemental Fig. S1). In line 
with these results, plasmatic levels of leptin were signifi-
cantly increased in male mice after 28 days of HFD feeding 
compared with control diet, whereas female mice did not 
show hyperleptinemia until 60 days of HFD administration, 
and leptin levels were considerably lower at this point than 
those observed in male mice (Fig. 1B). These data show 
that male mice became obese and hyperleptinemic at ear-
lier time points of HFD feeding than females, and the final 
body weights remained higher in comparison to female 
mice (Fig. 1A, B, supplemental Fig. S1).
As expected, total caloric intake in male and female 
mice was increased when the animals were fed an HFD, 
whereas food intake was decreased in HFD animals of both 
sexes compared with SD (supplemental Fig. S2). In addi-
tion, both caloric and food intake was significantly lower in 
female mice fed an SD or HFD in comparison to diet-
matched male animals (supplemental Fig. S2).
Short-term administration of an HFD induced a 
transient increase of both thermogenesis activation and 
hypothalamic eCB levels in male and female mice
The induction of thermogenesis in the interscapular 
BAT of male and female mice was analyzed at different 
time points during 90 days of HFD feeding, compared with 
SD (Fig. 1C–F). A substantial activation peak was reached 
in gene expression of thermogenic markers (Fig. 1C–E) 
and interscapular temperature (Fig. 1F) in the BAT of 
male and female mice after 7–14 days of an HFD when 
compared with an SD. Longer administration periods of 
HFD (from 28 days onwards) were not able to induce such 
a considerable activation of BAT thermogenesis (Fig. 1C–F). 
The activation of gene expression of thermogenic markers 
was higher in the BAT of female compared with male mice, 
particularly after 7, 14, and 28 days of an HFD (Fig. 1C–E). 
In addition, an increased basal expression of specific ther-
mogenic genes (Fig. 1C, D) and basal interscapular BAT 
temperature (Fig. 1F) was appreciated in female mice in 
comparison to male mice, as described previously in the 
literature (28, 29).
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Analysis of hypothalamic eCB levels also revealed a pro-
nounced transitory increase after short-term administra-
tion of an HFD (Fig. 2). Hypothalamic 2-AG levels were 
significantly increased after 7 days of HFD feeding in both 
male and female mice, and these values were progressively 
attenuated, reaching basal levels in a time-dependent 
manner (Fig. 2A). AEA levels in the hypothalamus of male 
and female mice remained elevated during 7–28 days of 
HFD feeding, whereas they were significantly reduced af-
ter longer exposure to an HFD (Fig. 2B). Interestingly, 
transitory hypothalamic increases in 2-AG and AEA were 
substantially higher in female than in male mice, and de-
creases were more pronounced in female than in male 
mice (Fig. 2). Hypothalamic concentrations of 2-AG and 
AEA (ng of eCB/mg of tissue) derived from the two differ-
ent sets of animals during dietary administration are 
shown in supplemental Table S2.
In summary, short-term exposure to an HFD induced a 
transitory activation of BAT thermogenesis and a transient 
increase in hypothalamic 2-AG and AEA in mice, and these 
responses were sexually dimorphic (Fig. 1, 2).
Hypothalamic eCB levels correlated with body weight 
gain, leptinemia, and brown fat thermogenesis
First, we analyzed the relationship between hypotha-
lamic eCB levels and body weight gain or plasma leptin 
levels in the animals fed the experimental diets. 2-AG and 
AEA levels in the hypothalamus showed a negative correla-
tion with both body weight gain (Fig. 3A–D) and lepti-
nemia (supplemental Fig. S3) in male and female mice. 
Then, evaluation of the relationship between eCBs in the 
hypothalamus and the mRNA expression levels of BAT 
thermogenesis activation revealed that hypothalamic 2-AG 
and AEA levels positively correlated with mRNA levels of 
Ucp1, Pgc1, and Prdm16 in the BAT of female mice (Fig. 
3F, H, supplemental Fig. S4). In male mice, this correlation 
was only significantly appreciated when analyzing 2-AG 
levels (Fig. 3E, G, supplemental Fig. S4).
These results indicate a negative association between eCB 
levels in the hypothalamus and obesity progression in male 
and female mice, but a positive association of hypothalamic 
eCBs with thermogenic activation in response to an HFD, 
particularly evidenced in female mice.
Fig. 1.  DIO development of male and female mice fed an SD or HFD for 90 days. A: Body weight gain. B: Plasmatic levels of leptin. C–E: 
Relative mRNA expression of the thermogenic markers UCP1 (C), PGC1 (D), and PRDM16 (E) in BAT of male and female mice fed an SD 
or HFD for 90 days (n = 8–10). F: Representative infrared thermal images and quantification of interscapular temperature adjacent to the 
BAT depot of male and female mice fed an SD or HFD for 7, 28, 60, and 90 days (n = 5). Statistical significance was determined by ANOVA 
and Bonferroni posttest. Error bars represent SEM. *P < 0.05; **P < 0.01; ***P < 0.001 versus its corresponding SD; #P < 0.05; ##P < 0.01; 
###P < 0.001 versus male under the same diet conditions; +P < 0.05; ++P < 0.01; +++P < 0.001 versus same gender fed an HFD for 7 days.
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Plasmatic eCBs increased after longer administration 
periods of an HFD and showed a negative correlation to 
hypothalamic eCB levels
In contrast to the hypothalamus, plasmatic levels of 2-AG 
and AEA remained unchanged after short-term adminis-
tration of an HFD compared with SD in both male and 
female mice (Fig. 4A, B). However, exposure to an HFD 
for 60 or 90 days revealed an increase in plasmatic 2-AG in 
both male and female mice (Fig. 4A) and a substantial in-
crease in plasmatic AEA, particularly observed in female 
mice (Fig. 4B). In addition, 2-AG and AEA levels in plasma 
evidenced a positive correlation with body weight gain in 
Fig. 2. Time profile of hypothalamic eCB levels dur-
ing the development of DIO in male and female mice. 
A: Relative amount of 2-AG to male SD. B: Relative 
amount of AEA to male SD. Statistical significance was 
determined by ANOVA and Bonferroni posttest. Error 
bars represent SEM (n = 8–10). *P < 0.05; **P < 0.01; 
***P < 0.001 versus its corresponding SD; ###P < 0.001 
versus male under the same diet conditions; +++P < 
0.001 versus same gender fed an HFD for 7 days.
Fig. 3. Correlation between hypothalamic eCBs and body weight or UCP1 mRNA expression in BAT. Hypothalamic 2-AG levels negatively 
correlate with body weight at time of euthanization in both male (A) and female (B) mice. Hypothalamic AEA levels negatively correlate with 
body weight at time of euthanization in both male (C) and female (D) mice. Hypothalamic 2-AG levels positively correlate with UCP1 mRNA 
expression in BAT of male (E) and female (F) mice. Hypothalamic AEA levels do not correlate with UCP1 mRNA expression in BAT of male 
mice (G), but they positively correlate in BAT of female mice (H). Statistical significance and correlation was determined by Pearson correla-
tion coefficients (xy values = 30–40). **P < 0.01; ***P < 0.001.
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both male and female mice (Fig. 4C–F). Analysis of the re-
lationship between plasmatic and hypothalamic eCB levels 
revealed that plasmatic eCBs negatively correlated with 
those levels in the hypothalamus of male and female mice 
fed an HFD (supplemental Fig. S5). Plasmatic concentra-
tions of 2-AG and AEA (ng of eCB/ml of plasma) derived 
from the two different sets of animals during dietary ad-
ministration are shown in supplemental Table S3.
Short-term HFD feeding increased gene expression of 
eCB synthesis enzymes in the hypothalamus
We analyzed gene expression of the enzymes responsible 
for the synthesis (Dagl, Dagl, and Nape) and degradation 
(Mgll, Abhd6, and Faah) of 2-AG and AEA in the hypothala-
mus of mice fed an SD or HFD for 7 days. This analysis re-
vealed a significant increase in the expression of the 
hypothalamic enzymes synthetizing 2-AG and AEA after 
short-term HFD administration, whereas this increase was 
not evidenced in the expression of degradation enzymes 
(Fig. 5). Overall, this result shows that the transient in-
crease in hypothalamic 2-AG and AEA over 7 days of HFD 
feeding concurs with an enhanced expression of synthesis 
enzymes in the hypothalamus.
Acute leptin and a 3-adrenergic agonist both induced a 
thermogenic response with an increase in hypothalamic 
eCB levels
We decided to measure the levels of hypothalamic eCBs 
in another condition well known to activate BAT thermo-
genesis, such as central leptin administration and ip ad-
ministration of a 3-adrenergic agonist. In agreement with 
our previous results (23), 4 h of leptin icv increased gene 
expression of thermogenic markers in BAT (Fig. 6A). Un-
der these experimental conditions, hypothalamus of the 
same animals evidenced a significant increase in both 2-AG 
and AEA concentrations (Fig. 6B).
To compare the effects of central leptin versus periph-
eral adrenergic activation of BAT, mice received ip injec-
tion of the potent and selective 3-adrenergic agonist CL 
316,243, an agonist that has demonstrated minimal access 
to the brain after peripheral injection (30). In line with 
leptin experiment, CL 316,243 induced adrenergic activa-
tion of BAT thermogenesis marker genes (Fig. 6C), with a 
substantial increase in both 2-AG and AEA in the hypothal-
amus (Fig. 6D), revealing an association between hypotha-
lamic eCBs and thermogenesis activation.
Fig. 4. Time profile of plasmatic eCBs levels during the development of DIO and correlation to body weight in male and female mice. A: 
Relative amount of 2-AG compared with values found in male SD. B: Relative amount of AEA compared with values found in male SD. Plas-
matic 2-AG levels positively correlate with body weight at time of euthanization in both male (C) and female (D) mice. Plasmatic AEA levels 
positively correlate with body weight at time of euthanization in both male (E) and female (F) mice. Statistical significance was determined 
by ANOVA and Bonferroni posttest, and correlation was determined by Pearson correlation coefficients (xy values = 33–39). Error bars rep-
resent SEM (n = 8–10). *P < 0.05; **P < 0.01; ***P < 0.001 versus its corresponding SD; #P < 0.05; ##P < 0.01; ###P < 0.001 versus male mice 
under the same diet conditions.
Fig. 5. Relative mRNA expression of 2-AG and AEA synthesis and 
degradation enzymes in hypothalamus of male mice fed an SD or 
HFD for 7 days. Statistical significance was determined by ANOVA 
and Bonferroni posttest. Error bars represent SEM (n = 5–8). *P < 
0.05 versus SD.
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Acute central administration of 2-AG + AEA did not 
induce BAT thermogenesis
Icv administration of the mixture of the eCBs, 2-AG + 
AEA, in two different doses for 4 h, was not able to induce 
a significant alteration of either interscapular BAT tem-
perature (Fig. 7A) or gene expression levels of thermo-
genic markers in BAT (Fig. 7B). Food intake was not 
significantly altered in response to icv injection of the 
doses of these eCBs (data not shown), in agreement with a 
previous publication (25).
DISCUSSION
Despite the well-established function of the eCB system 
on energy homeostasis, our knowledge on its exact dynamic 
and regulation under dietary conditions leading to obesity 
and associated complications is still limited. Our current 
study presents for the first time the temporal profile of hy-
pothalamic eCB changes during the development of DIO 
and its association with BAT thermogenesis activation and 
leptin response in male and female mice. This is an intrigu-
ing finding, considering the very few and contradictory evi-
dence that exists in the literature on hypothalamic eCBs in 
response to an HFD, its relation to BAT activation, and the 
potential contribution of this association to sexual dimor-
phism in obesity.
One of the most remarkable results in our study was the 
transitory and substantial increase in hypothalamic eCBs 
after short-term administration of an HFD in both male 
and female mice, while these levels were progressively at-
tenuated under long-term exposure to this diet. The tran-
sient increase was particularly pronounced on 2-AG levels 
after 7 days of HFD feeding (four to six times higher than 
the basal levels). At this time point, the early rise on eCB 
levels was sustained by a significant increase in the hypotha-
lamic expression of the enzymes responsible for the synthe-
sis of 2-AG and AEA, without significant alterations in 
degrading enzyme expression.
It has been reported that eCB levels become deregulated 
in the hypothalamus during obesity (7, 9). Di Marzo et al. 
(9) were the first detecting elevated levels of 2-AG in ge-
netically obese Zucker rats and ob/ob mice and of both 
2-AG and AEA in the hypothalamus of db/db mice, com-
pared with lean controls. Because those genetic models are 
either leptin-deficient or express mutated forms of the 
leptin receptor, the increased eCB levels in the hypothala-
mus were suggested as an additional component of leptin-
sensitive regulatory mechanisms (9). Studies on DIO 
animals, the model that best resembles human obesity, are 
scarce and controverted in terms of hypothalamic eCB 
changes. Moreover, some of these investigations are lim-
ited to their analysis after long-term HFD administration 
(19 weeks onward) and thereby when obesity has been al-
ready established (14, 15). Our current data show that hy-
pothalamic 2-AG and AEA levels are not increased when 
DIO is established (at 60 or 90 days of an HFD), but they are 
at earlier stages (7–28 days) of high-fat feeding, in contrast 
Fig. 6. Hypothalamic eCB levels and BAT thermogenesis in response to acute icv leptin (A, B) or to ip injection of the 3-adrenoreceptor 
agonist CL 316,243 (C, D) in lean mice fed a chow diet. Relative mRNA expression of the thermogenic markers in BAT samples after 4 h of 
icv leptin (A) or ip CL 316,243 administration (C). Concentration of 2-AG and AEA in the hypothalamus of mice after 4 h of icv leptin (B) 
or ip CL 316,243 administration (D). Statistical significance was determined by ANOVA and Bonferroni posttest. Error bars represent SEM 
(n = 8–12). *P < 0.05; **P < 0.01; ***P < 0.001 versus vehicle.
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to that observed in plasma. These data indicate that the 
eCB dynamic in the hypothalamus is different in genetic 
animal models of obesity compared with diet-induced 
obese models. Furthermore, this is the first time that a 
negative association between hypothalamic eCBs and body 
weight during DIO development is demonstrated.
Our group has recently reported that the robust activa-
tion peak of BAT thermogenesis observed under 7 days of 
HFD feeding matches with a transient preservation of nor-
mal body weight, adiposity, and leptinemia in the initial 
phases of DIO (23). The fact that the transitory increase in 
hypothalamic eCBs after short-term HFD administration 
found in the present investigation correlated with the acti-
vation peak of BAT thermogenesis led us to propose this 
early rise in hypothalamic eCBs as a physiological compen-
satory response (found in the hypothalamus, but not in 
plasma) to BAT thermogenesis activation triggered by diet 
surplus. These data also suggest the existence of a cross-talk 
between BAT and hypothalamic eCBs in the initial stages 
of obesity.
The link between the increase in hypothalamic 2-AG and 
AEA levels and BAT thermogenesis activation was further 
evaluated by measuring hypothalamic eCBs following acute 
thermogenic activation by different stimuli. Acute adminis-
tration of either central leptin or ip injection of CL 316,243, 
a selective and peripherally restricted 3-adrenergic ago-
nist, induced BAT thermogenesis activation with a substan-
tial increase in hypothalamic eCB levels. This is the first 
study revealing that acute stimulation of BAT enhances 
eCB levels in the hypothalamus. In relation to these find-
ings, it was recently demonstrated that in vivo stimulation 
of 3-adrenoreceptors in brown adipocytes by CL 316,243 
(acutely or chronically injected) elevated the levels of the 
eCBs, 2-AG and AEA, in BAT and were suggested to act as 
local autocrine negative-feedback regulators (27). Our as-
sumption that the hypothalamic eCB elevation is a com-
pensatory response, and not a cause, to BAT thermogenesis 
activation was also supported by the absence of stimulation 
of thermogenesis under icv administration of different 
doses of the combination of 2-AG + AEA. The lack of BAT 
activation by central eCB injection, at least with the se-
lected dosages, suggests the unidirectional link from BAT 
to hypothalamic eCBs. However, further research is needed 
to unravel the molecular mechanisms by which BAT is pos-
sibly signaling the hypothalamic eCB system, particularly in 
early stages of DIO development.
Therefore, the present investigation shows evidence 
that, in early stages of obesity, when BAT thermogenesis is 
more active, there is a higher increase in hypothalamic 
eCBs, as a physiological compensatory response to BAT ac-
tivation. However, when DIO is already established, the de-
cline of thermogenesis activation is accompanied by a 
decrease in hypothalamic eCB levels. Further investigation 
will be needed to study the specific role of hypothalamic 
eCBs in response to BAT activation.
Interestingly, we can find in the literature other exam-
ples of short-term changes in the hypothalamus in response 
to nutritional surplus suggested to be compensatory mech-
anisms in obesity (31–33). These changes have also been 
described as processes preceding insulin/leptin sensitivity 
disruption and inflammation in peripheral tissues and there-
fore promoting positive energy balance (34, 35). There-
fore, we might also understand the transitory increase in 
hypothalamic eCBs as an early indicator to precede leptin 
resistance and peripheral obesity.
Despite the discrepancy on central eCBs during DIO, the 
dysregulation of circulating eCB levels in metabolic diseases 
have been widely investigated (1–3). To date, these data are 
more conclusive, and the results on plasmatic eCBs in ro-
dents are similar to those observed in humans (1, 36–38). 
Circulating eCBs positively correlate with markers of obesity 
and metabolic disorders, such as BMI, waist circumference, 
visceral fat mass, and insulin resistance (5, 6, 37, 39, 40). 
Our data on circulating eCBs agree with those previously 
reported—that is, plasmatic 2-AG and AEA levels were in-
creased, particularly in female mice, after long-term expo-
sure to an HFD, but not at early stages of DIO. Interestingly, 
Fig. 7. BAT thermogenesis in response to acute icv injection of 
the eCBs 2-AG and AEA to lean mice, in two different dosages: dose 
1 (0.5 µg 2-AG + 0.005 µg AEA) and dose 2 (2 µg 2-AG + 0.02 µg 
AEA). Representative infrared thermal images and the correspond-
ing quantification of interscapular temperature adjacent to the BAT 
depot (iBAT) (A) and relative mRNA expression of the thermo-
genic marker UCP1 (B) in BAT samples of mice after 4 h of icv in-
jection of 2-AG + AEA in two different dosages. Statistical significance 
was determined by ANOVA and Bonferroni posttest. Error bars rep-
resent SEM (n = 8–10).
1268 Journal of Lipid Research Volume 60, 2019
these results negatively correlated with those concentra-
tions in the hypothalamus. In line with these evidences, Kui-
pers et al. (41) recently demonstrated that there is a link 
between eCB metabolism in adipose tissues and plasmatic 
eCBs during DIO development. They showed that long-
term HFD feeding increases circulating eCBs, accompanied 
by increased synthesis enzymes in adipose tissue (particu-
larly BAT) of DIO mice (41). The authors also suggest that 
adipose tissues are likely important organs that release 2-AG 
and AEA levels in HFD-induced obesity (41).
An important finding in the current investigation was 
the difference in eCB levels observed depending on the 
gender. Relevant differences were appreciated between 
male and female mice, particularly when analyzing the 
transient increase of hypothalamic eCBs and the peak of 
activation of thermogenesis after a short-term HFD, which 
were substantially higher in females. In addition, obesity 
progression was delayed and less severe in females, suggest-
ing a sexual dimorphism in hypothalamic eCB systems that 
could determine obesity progression. The relationship of 
central eCB systems and sexual dimorphism in obesity has 
been poorly explored (16). Recent findings on hypotha-
lamic dimorphism in fatty acid concentration, chain 
length, and saturation, in response to HFD feeding were 
associated with protection to obesity and cardiovascular 
diseases in female compared with male mice (17, 19). Our 
data are the first comparing the dynamic of hypothalamic 
eCBs between male and female mice during DIO develop-
ment. These results are therefore contributing to elucidate 
the relevance of central lipid metabolism in the sexual di-
morphism in obesity.
Overall, this is the first study revealing the exact dynamic 
of hypothalamic eCBs during the development of obesity 
in DIO models, and these temporal changes correlated 
positively to BAT thermogenesis and negatively to circulat-
ing eCB, leptin, and body weight. Our data evidence a tran-
sitory elevation in hypothalamic eCBs after short-term HFD 
feeding accompanied by increased expression of 2-AG and 
AEA synthesis enzymes, understood as a physiological com-
pensatory response to BAT thermogenesis activation trig-
gered by diet surplus. The link between hypothalamic eCBs 
and BAT thermogenesis activation was also supported by a 
substantial upregulation of eCB in the hypothalamus fol-
lowing acute thermogenic activation by central leptin or 
peripheral 3-adrenergic stimulation. Our findings could 
add significant insight into the understanding of the hypo-
thalamic mechanisms regulating obesity progression and 
its relationship to BAT function.
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